Clinical trial · Interventional
Exercise Prehabilitation for Locoregional Esophageal Cancer
Exercise Prehabilitation for Locoregional Esophageal Cancer: A Pilot Study
NCT06430346CI-TRIAL-00098426recruitingN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of the study is to examine the feasibility and acceptability of exercise "prehabilitation" for patients preparing for esophageal cancer resection (removal).
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Esophageal Cancer | Malignant Esophageal Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Exercise | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Exercise prehabilitation
- description
- In this trial participants will participate in an exercise program for 5 to 17 weeks, varying with treatment plans. Participants will receive resistance training equipment and participate in resistance training sessions twice per week (approximately 30-45 minutes per session). A Fitbit device will be provided to monitor step counts.
- interventionNames
- Behavioral: Exercise
Primary outcomes (1)
- measure
- Retention
- timeFrame
- Up to 11 weeks
- description
- The number of participants who complete T0 and T1 measures.
Secondary outcomes (2)
- measure
- Exploratory outcomes and changes
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Biopsy-proven locoregional esophageal cancer (LEC) * Eastern Cooperative Oncology Group (ECOG) performance status 0-2 * Treatment plan including neoadjuvant chemoradiation therapy and surgical resection * Ability to read and speak English Exclusion Criteria: * Regular engagement in resistance training (2x/week targeting all major muscle groups) * Screen failure for exercise safety based on PAR-Q * Underlying unstable cardiac or pulmonary disease or symptomatic cardiac disease * Recent fracture or acute musculoskeletal injury that precludes ability to participate in resistance training safely * Numeric pain rating scale of 7 or more out of 10 * Myopathic or rheumatologic disease that impacts physical function
References
Publications (0)
Data not yet available
No reference posted for this study.